Orion Nutraceuticals Inc. (CSE:ORI) has launched its campaign on the Investing News Network’s Cannabis channel.

Orion Nutraceuticals is a Canadian cannabis life science company primarily focused on developing a footprint in Colombia’s medicinal cannabis market. The company owns cannabis facilities in Colombia and Canada that are dedicated to cultivating CBD strains that meet the needs of the sports medicine market. The sports medicine space has recently seen the decriminalization of CBD from regulatory bodies like the World Anti Doping Agency (WADA).


In Colombia, Orion Nutraceuticals has partnered with FMC Global SAS, the country’s first licensed producer and exporter of non-psychoactive medical cannabis extracts. Orion Nutraceutical is working towards obtaining a 49 percent interest in FCM Global, who owns a 235,800-square-foot facility in La Ceja, Antioquia, Colombia. The company expects the facility to be able to produce 50 tons of extract by 2020. In Canada, meanwhile, Orion Nutraceuticals owns 99 percent of Medic Oasis, a late-stage production license applicant and owner of a 31,688-square-foot growing, manufacturing and distribution facility in Dorval, Quebec.

Orion Nutraceuticals’ company highlights include the following:

  • Operating in low-cost growing environments of Colombia and Quebec.
  • Import and export potential from Colombia and Canada.
  • La Ceja facility will be able to produce 50 tons of extract by 2020.
  • Tolima facility is expected to generate $1 billion in revenue by 2023.
  • First mover advantage as a cannabis company in the sports therapy market.
  • Planned partnerships with leading research organizations, professional athletes and sports leagues to introduce and promote their products.
  • Product lines to include medicinal and over-the-counter products, as well as bulk extracts and oils.

Click here to see the educational profile for Orion Nutraceuticals Inc. (CSE:ORI) and to request an investor presentation.

Strong Innovation Pipeline Continues to Drive Market Share Growth
Broken Coast’s First Foray into Cannabis 2.0
Solei Introduces First Limited Release Vape on the Market
Solei, RIFF, Good Supply and B!NGO Expand Product Offerings

Aphria Inc. (” Aphria ” or the ” Company “) ( TSX: APHA and NASDAQ: APHA ), a leading global cannabis company inspiring and empowering the worldwide community to live their very best life, today announced the expansion of its 510 Vape offering across its award-winning adult-use brand portfolio.

Keep reading... Show less

Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of Aurora Cannabis Inc. (NYSE: ACB) between February 13, 2020 and September 4, 2020, inclusive (the “Class Period”). If you wish to serve as lead plaintiff, you must move the Court before the December 1 2020 DEADLINE . A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

To join the class action, go to http://zhanginvestorlaw.com/join-action-form/?slug=aurora-cannabis-inc&id=2437 or call Sophie Zhang, Esq. toll-free at 800-991-3756 or email info@zhanginvestorlaw.com for information on the class action.

Keep reading... Show less

Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) (“Nextleaf Solutions“, “OILS”, or the “Company”), Canada’s most innovative cannabis extractor, is pleased to provide the following commercial and intellectual property update:

Cannabis Extraction Agreement with White Label Producer

Keep reading... Show less

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES

Khiron Life Sciences Corp. (“ Khiron ” or, the “ Company ”) (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe, is pleased to announce that it has closed today its previously announced “bought deal” short form prospectus offering of units (“ Unit s ”), including the exercise in full of the over-allotment option (the “ Offering ”).

Keep reading... Show less

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein, Executive Chairman, is scheduled to speak on a panel at the Cowen 2020 Boston Cannabis Conference on Wednesday, December 2, 2020 at 9:20 a.m. EST.

For more information regarding the Cowen 2020 Boston Cannabis Conference please visit: https://www.cowen.com/conferences-and-events/3rd-annual-boston-cannabis-conference/

Keep reading... Show less